voriconazole NDC 72162-1198

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-1198Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-1198Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-1198-3	72162119803	30 TABLET, FILM COATED in 1 BOTTLE (72162-1198-3)Marketed from May 13, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): voriconazole
Generic name (nonproprietary): voriconazole
Active ingredients: Voriconazole — 200 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200265
Marketing start: May 13, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Azoles (Chemical structure)Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
Identifiers: Product ID 72162-1198_350989fb-8ab1-94a3-e063-6394a90a1a9aSPL ID 350989fb-8ab1-94a3-e063-6394a90a1a9aSPL set ID 35098192-3bcb-9111-e063-6394a90ae8eaRxCUI 349434UNII JFU09I87TR
Pharmacologic class: Azole Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162119803 followed by a unit qualifier and the quantity

Package 72162-1198-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 13, 2025.

Indications (excerpt from the label)

Voriconazole tablets are an azole antifungal indicated for the treatment of adults and pediatric patients aged 12 to 14 years weighing greater than or equal to 50 kg and those aged 15 years and older regardless of body weight with: Invasive aspergillosis ( 1.1 ) Candidemia in non-neutropenics and other deep tissue Candida infections ( 1.2 ) Esophageal candidiasis ( 1.3 ) Serious fungal infections caused by Scedosporium apiospermum and Fusarium species including Fusarium solani , in patients intolerant of, or refractory to, other therapy ( 1.4 ) 1.1 Invasive Aspergillosis Voriconazole tablets are indicated in adults and pediatric patients (aged 12 to 14 years weighing greater than or equal to…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200265

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200265
Product	Strength	Form · route	Labeler	Product NDC
voriconazole	Voriconazole 200 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2911
voriconazole	Voriconazole 50 mg/1	Tablet, Film coatedOral	Sandoz Inc	0781-5667
voriconazole	Voriconazole 200 mg/1	Tablet, Film coatedOral	Sandoz Inc	0781-5668
voriconazole	Voriconazole 200 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-8734